TipRanks
Rafarma Pharmaceuticals Inc (RAFA)
OTHER OTC:RAFA
US Market
RAFA
Rafarma Pharmaceuticals
RESEARCH TOOLSreports

Rafarma Pharmaceuticals (RAFA) Income Statement

14 Followers

Rafarma Pharmaceuticals Income Statement

Last quarter (Q4 2025), Rafarma Pharmaceuticals's total revenue was $308.00K, an increase of 185.19% from the same quarter last year. In Q4, Rafarma Pharmaceuticals's net income was $82.00K. See Rafarma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 9.18M$ 9.08M$ 10.13M$ 64.31M$ 77.41M
Gross Profit
$ 761.00K$ 674.00K$ 600.00K$ 22.81M$ 27.27M
Operating Expenses
$ 272.00K$ 269.00K$ 287.00K$ 15.66M$ 12.55M
Depreciation and Amortization
$ 0.00$ 0.00$ 167.90K$ 228.49K$ 236.56K
EBITDA
$ 489.00K$ 342.00K$ 526.89K$ 6.45M$ 14.72M
Operating Income
$ 489.00K$ 405.00K$ 313.00K$ 7.15M$ 14.72M
Other Income/Expenses
$ -62.00K$ -62.00K$ 47.00K$ -925.00K$ -138.00K
Pretax Income
$ 427.00K$ 343.00K$ 360.00K$ 6.22M$ 14.59M
Net Income
$ 349.00K$ 266.00K$ 273.00K$ 4.96M$ 11.57M
Per Share Metrics
Basic EPS
$ <0.01$ <0.01$ 0.00$ 0.06$ 0.13
Diluted EPS
$ <0.01$ <0.01$ 0.00$ 0.06$ 0.13
Weighted Average Shares Outstanding
 87.77M 87.77M 87.77M 87.77M 87.77M
Weighted Average Shares Outstanding (Diluted)
 87.77M 87.77M 87.77M 87.77M 87.77M
Currency in USD

Rafarma Pharmaceuticals Earnings and Revenue History